GATA6 expression with CA19-9 levels as biomarkers in resectable pancreatic adenocarcinoma treated with neoadjuvant modified FOLFIRINOX in the NeoPancONE trial.
Rich Ericson King, Ronan Andrew McLaughlin, Derek J. Jonker, Paul J. Karanicolas et autres
ca (code pays fourni par la source)